Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

US leading manufacturer seeks out Medical Kiwi relationship

26 November 2019

US leading nutraceutical manufacturer seeks out Medical Kiwi relationship

Recognising New Zealand as the next global player in medicinal cannabis, a leading American manufacturer of dietary supplements approached Medical Kiwi about working together. Last week, Empirical Labs and Medical Kiwi directors signed a memorandum of understanding (MoU) at Empirical Labs head office in Fort Collins, Colorado.

Established in December 2018, Medical Kiwi was the first medicinal cannabis company in the South Island to be granted a cultivation license by the Ministry of Health, allowing the company to establish a cannabis breeding programme for research and development for medicinal cannabis.

Poised to provide New Zealanders with the medicinal cannabis products they need once the Misuse of Drugs (Medicinal Cannabis) Amendment Act is passed this December, and for when the Medicinal Cannabis Scheme is up and running in 2020, Medical Kiwi has been furthering its strategy of cementing strategic international relationships, the latest being with Empirical Labs.

Medical Kiwi has already secured an uptake deal and signed an MoU with UK distributor Liberty Herbal Technologies Ltd, giving Medical Kiwi the rights to sell Liberty’s medicinal cannabis products and allowing Medical Kiwi to supply Liberty with medicinal cannabis for its hapac® devices sold globally. Medical Kiwi has also signed an exclusive distribution deal with Vitality CBD Limited, allowing Medical Kiwi to import and sell Vitality CBD’s full range of 0% THC products, currently sold across the UK including in Boots stores, Tesco supermarkets, pharmacies and health stores.

Describing last week’s signing, Kelly Goyen Empirical Labs’ CEO says it ensures both companies are well placed to take advantage of the ever-growing cannabinoid market.

“When we met with Medical Kiwi, our distinct synergies were obvious,” Goyen says. “We both strive to bring innovative and ground-breaking products for customers.

“This growth industry will come with challenges, however, in our experience a focus on innovation and having a clear Go-to-Market strategy overcomes any challenges,” he says. “Empirical Labs has a simple ethos, which is to establish long term partnerships with our key customers, with the goal of developing exceptional products. We know that together Empirical Labs’ and Medical Kiwi’s teams will make a huge impact in the market. It is exciting times.”

Medical Kiwi Chairperson Aldo Miccio says the MoU with Empirical Labs is a coup for the company, and the New Zealand industry.

“The world’s eyes are on New Zealand and we were extremely pleased that a global leader with 30 years’ experience in formulation and optimal ways of delivering pharmaceuticals, came through our door to work with us,” says Miccio.

“Our new relationship with Empirical Labs means that we can get proven cannabis products quicker to market as they are ahead of New Zealand in research and development,” he says. “We also have an opportunity to develop some very exciting IP with Empirical Labs as we work together to develop new and unique medicinal cannabis products.

“As well as gaining immediate access to product innovations, their strong team complements our team, so we can share expertise while learning from their experience. It is a win-win,” he says.

Miccio adds that in the future Medical Kiwi will also supply Empirical Labs with its own dried Nelson Tasman-produced cannabis for the uniquely co-created medicinal and wellness products.

Medical Kiwi Directors Dr Michael Packer and Dr David Porter visited Empirical Labs last week. Dr Porter says they were very impressed with Empirical’s facilities and processes.

“Empirical Labs demonstrated extreme attention to detail with respect to ingredient selection, solvent-free extraction and manufacturing processes,” says Dr Porter. “They have developed a new way of packaging product in microsomes - tiny balls of natural fat that transport the product across the gut lining and through the liver before releasing the product into the body.

“What that means is far more of the dose gets where it’s needed as the gut and liver break down a big proportion of an oral dose before it even reaches the bloodstream and target tissue,” he says. “It is very impressive.”

More information can be found on the Medical Kiwi website. www.medicalkiwi.com and at www.facebook.com/MedicalKiwiNZ/.


ends

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

TradeMe: Property Prices In Every Region Hit New High For The Very First Time

Property prices experienced their hottest month on record in December, with record highs in every region, according to the latest Trade Me Property Price Index.\ Trade Me Property spokesperson Logan Mudge said the property market ended the year with ... More>>

Motor Industry Association: 2020 New Vehicle Registrations Suffer From Covid-19

Chief Executive David Crawford says that like some other sectors of the New Zealand economy, the new vehicle sector suffered from a case of Covid-19. Confirmed figures for December 2020 show registrations of 8,383 were 25% ... More>>

CTU 2021 Work Life Survey: COVID And Bullying Hit Workplaces Hard, Huge Support For Increased Sick Leave

New data from the CTU’s annual work life survey shows a snapshot of working people’s experiences and outlook heading out of 2020 and into the new year. Concerningly 42% of respondents cite workplace bullying as an issue in their workplace - a number ... More>>

Smelter: Tiwai Deal Gives Time For Managed Transition

Today’s deal between Meridian and Rio Tinto for the Tiwai smelter to remain open another four years provides time for a managed transition for Southland. “The deal provides welcome certainty to the Southland community by protecting jobs and incomes as the region plans for the future. The Government is committed to working on a managed transition with the local community,” Grant Robertson said. More>>

ALSO:

OECD: Area Employment Rate Rose By 1.9 Percentage Points In The Third Quarter Of 2020

OECD area employment rate rose by 1.9 percentage points in the third quarter of 2020, but remained 2.5 percentage points below its pre-pandemic level The OECD area [1] employment rate – the share of the working-age population with jobs – rose ... More>>

Economy: Strong Job Ad Performance In Quarter Four

SEEK Quarterly Employment Report data shows a positive q/q performance with a 19% national growth in jobs advertised during Q4 2020, which includes October, November and December. Comparing quarter 4, 2020, with the same quarter in 2019 shows that job ad volumes are 7% lower...More>>

NIWA: 2020 - NZ’s 7th-warmest Year On Record

The nationwide average temperature for 2020, calculated using stations in NIWA’s seven-station temperature series which began in 1909, was 13.24°C (0.63°C above the 1981–2010 annual average). New Zealand’s hottest year on record remains 2016, when... More>>

Quotable Value New Zealand: Property Market Set To Cool From Sizzling To Warm In 2021

Nostradamus himself could not have predicted the strange series of events that befell our world in 2020 – nor the wild trajectory of New Zealand’s property market, which has gone from “doom and gloom” to “boom and Zoom” in record time. Even ... More>>